Gandhy and colleagues found that curcumin and its synthetic analog RL197 induced ROS accumulation in colon cancer cells, which decreased expression of Sp1, Sp3, Sp4 and Sp-regulated genes, including EGFR [60]. The gene discussed is EGFR; the disease is malignant colon neoplasm.